- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Long-acting Injectable Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Long-acting Injectable Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Long-acting Injectable Medications market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Long-acting Injectable Medications market has been segmented into:
First-generation
Second-generation
By Application, Long-acting Injectable Medications has been segmented into:
Schizophrenia
Contraception
HIV
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Long-acting Injectable Medications market presented in the report. This section sheds light on the sales growth of different regional and country-level Long-acting Injectable Medications markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Long-acting Injectable Medications market.
The report offers in-depth assessment of the growth and other aspects of the Long-acting Injectable Medications market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Long-acting Injectable Medications Market Share Analysis
Long-acting Injectable Medications competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Long-acting Injectable Medications sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Long-acting Injectable Medications sales, revenue and market share for each player covered in this report.
The major players covered in Long-acting Injectable Medications are:
Eli Lilly
MedinCell
Zogenix
Alkermes
GSK
Johnson & Johnson
Nanomi
Mapi Pharma
DURECT
Oakwood Labs
Pharmathen
Kashiv BioSciences
Among other players domestic and global, Long-acting Injectable Medications market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Long-acting Injectable Medications Market Overview
1.1 Product Overview and Scope of Long-acting Injectable Medications
1.2 Classification of Long-acting Injectable Medications by Type
1.2.1 Global Long-acting Injectable Medications Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Long-acting Injectable Medications Revenue Market Share by Type in 2019
1.2.3 First-generation
1.2.4 Second-generation
1.3 Global Long-acting Injectable Medications Market by Application
1.3.1 Overview: Global Long-acting Injectable Medications Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Schizophrenia
1.3.3 Contraception
1.3.4 HIV
1.3.5 Others
1.4 Global Long-acting Injectable Medications Market by Regions
1.4.1 Global Long-acting Injectable Medications Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Long-acting Injectable Medications (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Long-acting Injectable Medications Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Long-acting Injectable Medications Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Long-acting Injectable Medications Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Long-acting Injectable Medications Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Long-acting Injectable Medications Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.2 MedinCell
2.2.1 MedinCell Details
2.2.2 MedinCell Major Business
2.2.3 MedinCell SWOT Analysis
2.2.4 MedinCell Product and Services
2.2.5 MedinCell Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.3 Zogenix
2.3.1 Zogenix Details
2.3.2 Zogenix Major Business
2.3.3 Zogenix SWOT Analysis
2.3.4 Zogenix Product and Services
2.3.5 Zogenix Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.4 Alkermes
2.4.1 Alkermes Details
2.4.2 Alkermes Major Business
2.4.3 Alkermes SWOT Analysis
2.4.4 Alkermes Product and Services
2.4.5 Alkermes Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK SWOT Analysis
2.5.4 GSK Product and Services
2.5.5 GSK Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Product and Services
2.6.4 Johnson & Johnson Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nanomi
2.7.1 Nanomi Details
2.7.2 Nanomi Major Business
2.7.3 Nanomi Product and Services
2.7.4 Nanomi Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mapi Pharma
2.8.1 Mapi Pharma Details
2.8.2 Mapi Pharma Major Business
2.8.3 Mapi Pharma Product and Services
2.8.4 Mapi Pharma Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.9 DURECT
2.9.1 DURECT Details
2.9.2 DURECT Major Business
2.9.3 DURECT Product and Services
2.9.4 DURECT Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.10 Oakwood Labs
2.10.1 Oakwood Labs Details
2.10.2 Oakwood Labs Major Business
2.10.3 Oakwood Labs Product and Services
2.10.4 Oakwood Labs Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pharmathen
2.11.1 Pharmathen Details
2.11.2 Pharmathen Major Business
2.11.3 Pharmathen Product and Services
2.11.4 Pharmathen Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
2.12 Kashiv BioSciences
2.12.1 Kashiv BioSciences Details
2.12.2 Kashiv BioSciences Major Business
2.12.3 Kashiv BioSciences Product and Services
2.12.4 Kashiv BioSciences Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Long-acting Injectable Medications Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Long-acting Injectable Medications Players Market Share
3.2.2 Top 10 Long-acting Injectable Medications Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Long-acting Injectable Medications Revenue and Market Share by Regions
4.2 North America Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
4.3 Europe Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
4.5 South America Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
5 North America Long-acting Injectable Medications Revenue by Countries
5.1 North America Long-acting Injectable Medications Revenue by Countries (2015-2020)
5.2 USA Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
5.3 Canada Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
5.4 Mexico Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
6 Europe Long-acting Injectable Medications Revenue by Countries
6.1 Europe Long-acting Injectable Medications Revenue by Countries (2015-2020)
6.2 Germany Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
6.3 UK Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
6.4 France Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
6.5 Russia Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
6.6 Italy Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Long-acting Injectable Medications Revenue by Regions
7.1 Asia-Pacific Long-acting Injectable Medications Revenue by Regions (2015-2020)
7.2 China Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
7.3 Japan Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
7.4 Korea Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
7.5 India Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
8 South America Long-acting Injectable Medications Revenue by Countries
8.1 South America Long-acting Injectable Medications Revenue by Countries (2015-2020)
8.2 Brazil Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
8.3 Argentina Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Long-acting Injectable Medications by Countries
9.1 Middle East & Africa Long-acting Injectable Medications Revenue by Countries (2015-2020)
9.2 Saudi Arabia Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
9.3 UAE Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
9.4 Egypt Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
9.5 South Africa Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Long-acting Injectable Medications Revenue and Market Share by Type (2015-2020)
10.2 Global Long-acting Injectable Medications Market Forecast by Type (2019-2024)
10.3 First-generation Revenue Growth Rate (2015-2025)
10.4 Second-generation Revenue Growth Rate (2015-2025)
11 Global Long-acting Injectable Medications Market Segment by Application
11.1 Global Long-acting Injectable Medications Revenue Market Share by Application (2015-2020)
11.2 Long-acting Injectable Medications Market Forecast by Application (2019-2024)
11.3 Schizophrenia Revenue Growth (2015-2020)
11.4 Contraception Revenue Growth (2015-2020)
11.5 HIV Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Long-acting Injectable Medications Market Size Forecast (2021-2025)
12.1 Global Long-acting Injectable Medications Market Size Forecast (2021-2025)
12.2 Global Long-acting Injectable Medications Market Forecast by Regions (2021-2025)
12.3 North America Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
12.4 Europe Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
12.6 South America Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Long-acting Injectable Medications Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Long-acting Injectable Medications by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Long-acting Injectable Medications Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Long-acting Injectable Medications Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Long-acting Injectable Medications Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Eli Lilly Corporate Information, Location and Competitors
Table 7. Eli Lilly Long-acting Injectable Medications Major Business
Table 8. Eli Lilly Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 9. Eli Lilly SWOT Analysis
Table 10. Eli Lilly Long-acting Injectable Medications Product and Solutions
Table 11. Eli Lilly Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. MedinCell Corporate Information, Location and Competitors
Table 13. MedinCell Long-acting Injectable Medications Major Business
Table 14. MedinCell Long-acting Injectable Medications Total Revenue (USD Million) (2018-2019)
Table 15. MedinCell SWOT Analysis
Table 16. MedinCell Long-acting Injectable Medications Product and Solutions
Table 17. MedinCell Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Zogenix Corporate Information, Location and Competitors
Table 19. Zogenix Long-acting Injectable Medications Major Business
Table 20. Zogenix Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 21. Zogenix SWOT Analysis
Table 22. Zogenix Long-acting Injectable Medications Product and Solutions
Table 23. Zogenix Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Alkermes Corporate Information, Location and Competitors
Table 25. Alkermes Long-acting Injectable Medications Major Business
Table 26. Alkermes Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 27. Alkermes SWOT Analysis
Table 28. Alkermes Long-acting Injectable Medications Product and Solutions
Table 29. Alkermes Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. GSK Corporate Information, Location and Competitors
Table 31. GSK Long-acting Injectable Medications Major Business
Table 32. GSK Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 33. GSK SWOT Analysis
Table 34. GSK Long-acting Injectable Medications Product and Solutions
Table 35. GSK Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Johnson & Johnson Corporate Information, Location and Competitors
Table 37. Johnson & Johnson Long-acting Injectable Medications Major Business
Table 38. Johnson & Johnson Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 39. Johnson & Johnson SWOT Analysis
Table 40. Johnson & Johnson Long-acting Injectable Medications Product and Solutions
Table 41. Johnson & Johnson Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Nanomi Corporate Information, Location and Competitors
Table 43. Nanomi Long-acting Injectable Medications Major Business
Table 44. Nanomi Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 45. Nanomi SWOT Analysis
Table 46. Nanomi Long-acting Injectable Medications Product and Solutions
Table 47. Nanomi Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Mapi Pharma Corporate Information, Location and Competitors
Table 49. Mapi Pharma Long-acting Injectable Medications Major Business
Table 50. Mapi Pharma Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 51. Mapi Pharma SWOT Analysis
Table 52. Mapi Pharma Long-acting Injectable Medications Product and Solutions
Table 53. Mapi Pharma Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. DURECT Corporate Information, Location and Competitors
Table 55. DURECT Long-acting Injectable Medications Major Business
Table 56. DURECT Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 57. DURECT SWOT Analysis
Table 58. DURECT Long-acting Injectable Medications Product and Solutions
Table 59. DURECT Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Oakwood Labs Corporate Information, Location and Competitors
Table 61. Oakwood Labs Long-acting Injectable Medications Major Business
Table 62. Oakwood Labs Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 63. Oakwood Labs SWOT Analysis
Table 64. Oakwood Labs Long-acting Injectable Medications Product and Solutions
Table 65. Oakwood Labs Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Pharmathen Corporate Information, Location and Competitors
Table 67. Pharmathen Long-acting Injectable Medications Major Business
Table 68. Pharmathen Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 69. Pharmathen SWOT Analysis
Table 70. Pharmathen Long-acting Injectable Medications Product and Solutions
Table 71. Pharmathen Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Kashiv BioSciences Corporate Information, Location and Competitors
Table 73. Kashiv BioSciences Long-acting Injectable Medications Major Business
Table 74. Kashiv BioSciences Long-acting Injectable Medications Total Revenue (USD Million) (2017-2018)
Table 75. Kashiv BioSciences SWOT Analysis
Table 76. Kashiv BioSciences Long-acting Injectable Medications Product and Solutions
Table 77. Kashiv BioSciences Long-acting Injectable Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Long-acting Injectable Medications Revenue (Million USD) by Players (2015-2020)
Table 79. Global Long-acting Injectable Medications Revenue Share by Players (2015-2020)
Table 80. Global Long-acting Injectable Medications Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Long-acting Injectable Medications Revenue Market Share by Regions (2015-2020)
Table 82. North America Long-acting Injectable Medications Revenue by Countries (2015-2020)
Table 83. North America Long-acting Injectable Medications Revenue Market Share by Countries (2015-2020)
Table 84. Europe Long-acting Injectable Medications Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Long-acting Injectable Medications Revenue (Million USD) by Regions (2015-2020)
Table 86. South America Long-acting Injectable Medications Revenue by Countries (2015-2020)
Table 87. South America Long-acting Injectable Medications Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Long-acting Injectable Medications Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Long-acting Injectable Medications Revenue Market Share by Countries (2015-2020)
Table 90. Global Long-acting Injectable Medications Revenue (Million USD) by Type (2015-2020)
Table 91. Global Long-acting Injectable Medications Revenue Share by Type (2015-2020)
Table 92. Global Long-acting Injectable Medications Revenue Forecast by Type (2021-2025)
Table 93. Global Long-acting Injectable Medications Revenue by Application (2015-2020)
Table 94. Global Long-acting Injectable Medications Revenue Share by Application (2015-2020)
Table 95. Global Long-acting Injectable Medications Revenue Forecast by Application (2021-2025)
Table 96. Global Long-acting Injectable Medications Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Long-acting Injectable Medications Picture
Figure 2. Global Long-acting Injectable Medications Revenue Market Share by Type in 2019
Figure 3. First-generation Picture
Figure 4. Second-generation Picture
Figure 5. Long-acting Injectable Medications Revenue Market Share by Application in 2019
Figure 6. Schizophrenia Picture
Figure 7. Contraception Picture
Figure 8. HIV Picture
Figure 9. Others Picture
Figure 10. Global Long-acting Injectable Medications Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Long-acting Injectable Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Long-acting Injectable Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Long-acting Injectable Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Long-acting Injectable Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Long-acting Injectable Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Long-acting Injectable Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Long-acting Injectable Medications Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Long-acting Injectable Medications Revenue Market Share in 2019
Figure 19. Global Top 10 Players Long-acting Injectable Medications Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Long-acting Injectable Medications Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Long-acting Injectable Medications Revenue Market Share by Regions (2015-2020)
Figure 23. Global Long-acting Injectable Medications Revenue Market Share by Regions in 2018
Figure 24. North America Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 25. Europe Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 27. South America Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 29. North America Long-acting Injectable Medications Revenue Market Share by Countries (2015-2020)
Figure 30. North America Long-acting Injectable Medications Revenue Market Share by Countries in 2019
Figure 31. USA Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 32. Canada Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 34. Europe Long-acting Injectable Medications Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Long-acting Injectable Medications Revenue Market Share by Countries in 2019
Figure 36. Germany Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 37. UK Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 38. France Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 39. Russia Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 40. Italy Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Long-acting Injectable Medications Revenue Market Share by Regions (2015-2020)
Figure 42. Asia-Pacific Long-acting Injectable Medications Revenue Market Share by Regions in 2019
Figure 43. China Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 44. Japan Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 45. Korea Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 46. India Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 48. South America Long-acting Injectable Medications Revenue Market Share by Countries (2015-2020)
Figure 49. South America Long-acting Injectable Medications Revenue Market Share by Countries in 2019
Figure 50. Brazil Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Long-acting Injectable Medications Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Long-acting Injectable Medications Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 55. UAE Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Long-acting Injectable Medications Revenue and Growth Rate (2015-2020)
Figure 58. Global Long-acting Injectable Medications Revenue Share by Type (2015-2020)
Figure 59. Global Long-acting Injectable Medications Revenue Share by Type in 2019
Figure 60. Global Long-acting Injectable Medications Market Share Forecast by Type (2021-2025)
Figure 61. Global First-generation Revenue Growth Rate (2015-2020)
Figure 62. Global Second-generation Revenue Growth Rate (2015-2020)
Figure 63. Global Long-acting Injectable Medications Revenue Share by Application (2015-2020)
Figure 64. Global Long-acting Injectable Medications Revenue Share by Application in 2019
Figure 65. Global Long-acting Injectable Medications Market Share Forecast by Application (2021-2025)
Figure 66. Global Schizophrenia Revenue Growth Rate (2015-2020)
Figure 67. Global Contraception Revenue Growth Rate (2015-2020)
Figure 68. Global HIV Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Long-acting Injectable Medications Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Long-acting Injectable Medications Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Long-acting Injectable Medications Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
Figure 74. Europe Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
Figure 76. South America Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Long-acting Injectable Medications Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
